Antimicrobial γ-AApeptides (WO2013112548): a patent evaluation

Bibliography

• Infectious Diseases Society of A. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011;52(Suppl 5):S397-428
   PubMedGoogle Scholar
• Marr AK, Gooderham WJ, Hancock RE. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 2006;6(5):468-72
   PubMed Web of Science ®Google Scholar
• Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006;24(12):1551-7
   PubMed Web of Science ®Google Scholar
• Choi S, Isaacs A, Clements D, et al. De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc Natl Acad Sci USA 2009;106(17):6968-73
   PubMed Web of Science ®Google Scholar
• Tew GN, Scott RW, Klein ML, et al. De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. Acc Chem Res 2009;43(1):30-9
   Web of Science ®Google Scholar
• Scott RW, DeGrado WF, Tew GN. De novo designed synthetic mimics of antimicrobial peptides. Curr Opin Biotechnol 2008;19(6):620-7
   PubMed Web of Science ®Google Scholar
• Zhang L, Dhillon P, Yan H, et al. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000;44(12):3317-21
   PubMed Web of Science ®Google Scholar
• Wu M, Maier E, Benz R, et al. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli biochemistry. 1999;38(22):7235-42
   Google Scholar
• Friedrich CL, Moyles D, Beveridge TJ, et al. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother 2000;44(8):2086-92
   PubMed Web of Science ®Google Scholar
• Chongsiriwatana NP, Patch JA, Czyzewski AM, et al. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci USA 2008;105(8):2794-9
   PubMed Web of Science ®Google Scholar
• Lehrer RI, Lu WY. Alpha-defensins in human innate immunity. Immunol Rev 2012;245:84-112
   PubMed Web of Science ®Google Scholar
• Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002;66(4):236-48
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta 1998;1376(3):391-400
   PubMed Web of Science ®Google Scholar
• Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005;3(3):238-50
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Sugishita K, Miyajima K. Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of gram-negative bacteria. FEBS Lett 1999;449(2-3):221-4
   PubMed Web of Science ®Google Scholar
• Sal-Man N, Oren Z, Shai Y. Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells. Biochemistry 2002;41(39):11921-30
   PubMed Web of Science ®Google Scholar
• Oren Z, Ramesh J, Avrahami D, et al. Structures and mode of membrane interaction of a short alpha helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy. Eur J Biochem 2002;269(16):3869-80
   PubMedGoogle Scholar
• Sitaram N, Nagaraj R. Host-defense antimicrobial peptides: importance of structure for activity. Curr Pharm Des 2002;8(9):727-42
   PubMed Web of Science ®Google Scholar
• Habets MGJL, Brockhurst MA. Therapeutic antimicrobial peptides may compromise natural immunity. Biol Lett 2012;8(3):416-18
   PubMed Web of Science ®Google Scholar
• Olsen CA, Ziegler HL, Nielsen HM, et al. Antimicrobial, hemolytic, and cytotoxic activities of beta-peptoid-peptide hybrid oligomers: improved properties compared to natural AMPs. ChemBioChem 2010;11(10):1356-60
   PubMed Web of Science ®Google Scholar
• Chongsiriwatana NP, Miller TM, Wetzler M, et al. Short alkylated peptoid mimics of antimicrobial lipopeptides. Antimicrob Agents Chemother 2011;55(1):417-20
   PubMed Web of Science ®Google Scholar
• Kapoor R, Wadman MW, Dohm MT, et al. Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2011;55(6):3054-7
   PubMed Web of Science ®Google Scholar
• Huang ML, Shin SB, Benson MA, et al. A comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents. ChemMedChem 2012;7(1):114-22
   PubMed Web of Science ®Google Scholar
• Kapoor R, Eimerman PR, Hardy JW, et al. Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011;55(6):3058-62
   PubMed Web of Science ®Google Scholar
• Karlsson AJ, Pomerantz WC, Weisblum B, et al. Antifungal activity from 14-helical beta-peptides. J Am Chem Soc 2006;128(39):12630-1
   PubMed Web of Science ®Google Scholar
• Karlsson AJ, Pomerantz WC, Neilsen KJ, et al. Effect of sequence and structural properties on 14-helical beta-peptide activity against Candida albicans planktonic cells and biofilms. ACS Chem Biol 2009;4(7):567-79
   PubMed Web of Science ®Google Scholar
• Karlsson AJ, Flessner RM, Gellman SH, et al. Polyelectrolyte multilayers fabricated from antifungal beta-peptides: design of surfaces that exhibit antifungal activity against Candida albicans. Biomacromolecules 2010;11(9):2321-8
   PubMed Web of Science ®Google Scholar
• Srinivas N, Jetter P, Ueberbacher BJ, et al. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science (New York, NY) 2010;327(5968):1010-13
   Google Scholar
• Obrecht D, Robinson JA, Bernardini F, et al. Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics. Curr Med Chem 2009;16(1):42-65
   PubMed Web of Science ®Google Scholar
• Hua J, Scott RW, Diamond G. Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activity. Mol Oral Microbiol 2010;25(6):426-32
   PubMed Web of Science ®Google Scholar
• Hua J, Yamarthy R, Felsenstein S, et al. Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans. Mol Oral Microbiol 2010;25(6):418-25
   PubMed Web of Science ®Google Scholar
• Claudon P, Violette A, Lamour K, et al. Consequences of isostructural main-chain modifications for the design of antimicrobial foldamers: helical mimics of host-defense peptides based on a heterogeneous amide/urea backbone. Angewandte Chemie Int Ed Engl 2010;49(2):333-6
   PubMed Web of Science ®Google Scholar
• Niu Y, Padhee S, Wu H, et al. Identification of gamma-AApeptides with potent and broad-spectrum antimicrobial activity. Chem Commun (Cambridge, England) 2011;47(44):12197-9
   PubMed Web of Science ®Google Scholar
• Niu Y, Padhee S, Wu H, et al. Lipo-gamma-AApeptides as a new class of potent and broad-spectrum antimicrobial agents. J Med Chem 2012;55(8):4003-9
   PubMed Web of Science ®Google Scholar
• Padhee S, Hu Y, Niu Y, et al. Non-hemolytic alpha-AApeptides as antimicrobial peptidomimetics. Chem Commun (Cambridge, England) 2011;47(34):9729-31
   PubMed Web of Science ®Google Scholar
• Schmitt MA, Weisblum B, Gellman SH. Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. J Am Chem Soc 2007;129(2):417-28
   PubMed Web of Science ®Google Scholar
• Mowery BP, Lee SE, Kissounko DA, et al. Mimicry of antimicrobial host-defense peptides by random copolymers. J Am Chem Soc 2007;129(50):15474-6
   PubMed Web of Science ®Google Scholar
• Ivankin A, Livne L, Mor A, et al. Role of the conformational rigidity in the design of biomimetic antimicrobial compounds. Angewandte Chemie Int Ed Engl 2010;49(45):8462-5
   PubMed Web of Science ®Google Scholar
• Niu Y, Wu H, Li Y, et al. AApeptides as a new class of antimicrobial agents. Org Biomol Chem 2013;11:4283-90
   PubMed Web of Science ®Google Scholar
• Wu H, Niu Y, Padhee S, et al. Design and synthesis of unprecedented cyclic gamma-AApeptides for antimicrobial development. Chem Sci 2012;3:2570-5
   Web of Science ®Google Scholar
• Li Y, Smith C, Wu H, et al. Short antimicrobial lipo-alpha/gamma-AA hybrid peptides. ChemBioChem 2014;10.1002/cbic.201402264
   Web of Science ®Google Scholar
• Li Y, Smith C, Wu H, et al. Lipidated cyclic gamma-AApeptides display both antimicrobial and anti-inflammatory activity. ACS Chem Biol 2014;9(1):211-17
   PubMed Web of Science ®Google Scholar
• Padhee S, Smith C, Wu H, et al. The development of antimicrobial alpha-aapeptides that suppress proinflammatory immune responses. ChemBioChem 2014;15:688-94
   PubMed Web of Science ®Google Scholar
• Hu Y, Amin MN, Padhee S, et al. Lipidated peptidomimetics with improved antimicrobial activity. ACS Med Chem Lett 2012;3(8):683-6
   PubMed Web of Science ®Google Scholar